InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: Honeycomb777 post# 79085

Thursday, 12/27/2018 12:09:16 PM

Thursday, December 27, 2018 12:09:16 PM

Post# of 140475

There really shouldn't be a lot of "nice to haves" for Gen 2. They have had a pile of top surgeons from around the world providing feedback for years at this point.

The concern about competition doesn't seem to be well founded at this point. Nobody has gone after Trixie yet. There has been very little news about patent infringement activity in the robotic surgery space. After ISRG's Computer Motion debacle, all teams seem to be concentrating hard on their intellectual property portfolios, and Titan has one of the best. Sure, it is always a possibility, but so far there is no evidence to support your concerns. Trixie, Medtronic, CMR... all at least as far along the development path as Titan and none of them seem worried, despite their systems having more in common with ISRG and with each other. No snake arms in the bunch; we should be cleaner than the others who are all using wristed end effectors or in-line wrist joints.


Message in reply to:
It really all comes down to this...do you / investors have the confidence that they will understand the impact of being able to wait for Gen 2 for the nice to haves ? We know another raise will be needed in 2-3 months

Here is what I see...I see the competition really starting to come at us soon (if not already) because they will NOT just let Titan waltz in and grab market share. So naturally, you would ask how could they do that - how could they make Titan's path more difficult ? Well:

- Lawsuits
- suppressing price by using their trading desk to short Titan each day
- enhancing their SP device (Intuitive)

My point is Titan is not just up against themselves but they will have to navigate the waters filled with hungry crocodiles (ie: competitors).